Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 28/09/2011
PIL COZAAR 12.5mg, 25 mg, 50 mg and 100 mg Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/09/2011 and displayed until Current
Reasons for adding or updating:
  • Extra statutory information
Updated on 11/02/2011 and displayed until 28/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 22/03/2010 and displayed until 11/02/2011
Reasons for adding or updating:
  • Change to packaging
  • Correction of spelling/typing errors
Updated on 15/08/2009 and displayed until 22/03/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
Updated on 19/05/2009 and displayed until 15/08/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to manufacturer contact details
Updated on 19/02/2009 and displayed until 19/05/2009
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to dosage and administration
  • Introduction of new strength
Updated on 25/01/2007 and displayed until 19/02/2009
Reasons for adding or updating:
  • Change to drug interactions
Updated on 08/12/2005 and displayed until 25/01/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to how to administer the medicine
  • Change to dosage and administration
Updated on 13/06/2005 and displayed until 08/12/2005
Reasons for adding or updating:
  • Change to packaging
Updated on 06/07/2004 and displayed until 13/06/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 27/09/2002 and displayed until 06/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 27/09/2002 and displayed until 27/09/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 11/02/2002 and displayed until 27/09/2002
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
  losartan potassium